Hong Kong stock market's innovative pharmaceutical sector continued to rise in the afternoon, with Zhaoyan Pharmaceuticals and Stone Pharmaceuticals Group both increasing by more than 10%.

In the afternoon, the Hong Kong stock market's innovative pharmaceutical sector continued to rise, with Zhaoyan Pharmaceuticals and Shiyao Group increasing by more than 10%, and Xinda Biotechnology rising by more than 7%. Junshi Biosciences and NovaQuest Pharmaceuticals followed the upward trend.